Tag: Hollister Biosciences Inc.
Hollister Biosciences Inc. Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2020
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it’s 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019
Hollister Biosciences Inc.’s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California
Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line
Allied Corp. and Hollister Biosciences Have Now Delivered TACTICAL RELIEF™ Products into Distribution
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Final $40 Million Revenue Milestone
